Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

Journal of Psychopharmacology - Tập 19 Số 6 - Trang 567-596 - 2005
David S. Baldwin1, Ian Anderson2, David Nutt3, Borwin Bandelow4, Alyson J. Bond5, Jonathan Davidson6, Johan A. den Boer7, Naomi Fineberg8, Martín Knapp5, Jan Scott5, Hans‐Ulrich Wïttchen9
1Division of Clinical Neurosciences, University of Southampton, Southampton, UK
2Department of Psychiatry, University of Manchester, Manchester, UK
3University of Bristol, Bristol, Psychopharmacology Unit, Bristol, UK
4Department of Psychiatry and Psychotherapy, University of Göttingen, Göttingen, Germany
5Institute of Psychiatry, King's College, London, UK
6Department of Psychiatry & Behavioral Science, Duke University Medical Center, Durham, USA
7School of Behavioral and Cognitive Neurosciences, University Medical Center Groningen, Groningen, the Netherlands
8Department of Psychiatry, University of Hertfordshire, Welwyn Garden City, UK
9Technical University of Dresden and Max Planck Institute of Psychiatry, Munich, Germany

Tóm tắt

These British Association for Psychopharmacology guidelines cover the range and aims of treatment for anxiety disorders. They are based explicitly on the available evidence and are presented as recommendations to aid clinical decision making in primary and secondary medical care. They may also serve as a source of information for patients and their carers. The recommendations are presented together with a more detailed review of the available evidence. A consensus meeting involving experts in anxiety disorders reviewed the main subject areas and considered the strength of evidence and its clinical implications. The guidelines were constructed after extensive feedback from participants and interested parties. The strength of supporting evidence for recommendations was rated. The guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments.

Từ khóa


Tài liệu tham khảo

10.1097/00004714-200206000-00012

10.1176/ajp.150.12.1878

10.1192/bjp.179.1.15

Allgulander C, ADAA meeting

10.1002/hup.602

10.1017/S1092852900006945

10.1176/appi.ajp.161.9.1642

10.1097/00004850-199907000-00006

American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Disorders, 4

10.1016/S0005-7967(96)00126-X

10.1177/026988110001400101

10.1111/j.1468-1331.2005.01196.x

10.1007/s00406-005-0576-8

10.1177/0269881103017002004

10.1097/00004850-200205000-00004

10.1097/00005053-199807000-00005

10.1517/14740338.3.5.457

Baldwin D S, 1998, J Clin Psychiatry, 59, S39

10.1017/S1461145704004870

10.1016/S0924-977X(04)80399-7

10.1176/ajp.155.1.36

Ballenger J C, 1998, J Clin Psychiatry, 59, 47

Ballenger J C, 1998, J Clin Psychiatry, 59, 54

Ballenger J C, 2001, J Clin Psychiatry, 62, 53

Ballenger J C, 2004, J Clin Psychiatry, 65, 55

10.3109/15622970209150621

10.1001/jama.283.19.2529

10.1176/ajp.154.9.1293

10.1007/s002130000372

10.1055/s-2004-832593

Bielski R J, 42nd Annual Meeting of the American College of Neuropsychopharmacology

10.1016/S0022-3999(01)00296-3

10.1017/S1461145703003791

10.1097/00004850-199603000-00005

10.1192/bjp.179.1.23

Bower P, 2001, Br J Gen Pract, 51, 838

10.1176/ajp.155.5.603

10.1037/0022-006X.63.3.408

10.1016/S0005-7916(03)00026-0

10.1037/0022-006X.71.6.1058

Committee on Safety of Medicines, 2004, Safety of selective serotonin reuptake inhibitor antidepressants

10.1001/archpsyc.60.8.837

10.1016/0165-1781(93)90030-K

10.1192/bjp.167.5.635

10.1002/(SICI)1522-7154(1996)2:1<13::AID-ANXI2>3.0.CO;2-E

10.1002/da.10063

10.1016/S0924-977X(00)00065-1

10.1186/1471-244X-4-16

10.1176/appi.ajp.158.12.1974

Davidson J R, American College of Neuropsychopharmacology

10.1097/01.jcp.0000155817.21467.6c

10.1001/archpsyc.61.10.1005

10.1136/bmj.328.7445.939

10.1097/01.jcp.0000125685.82219.1a

10.1097/00004850-198801000-00005

Den Boer J A, 1998, J Clin Psychiatry, 59, 30

10.1017/S003329170300179X

10.4088/JCP.v65n0803

Dowell A C, 1990, Br J Gen Pract, 40, 27

10.1016/0005-7967(87)90051-9

10.1017/S0033291702007079

Durham R C, Long-term outcome of cognitive behavior therapy clinical trials in central Scotland

10.1001/archpsyc.60.10.1024

10.1177/026988119801200401

10.1017/S0033291799002895

10.1016/S0005-7967(00)00114-5

10.1016/j.euroneuro.2004.04.004

10.1001/archpsyc.55.10.918

10.1016/S0924-9338(00)00215-7

10.1016/j.euroneuro.2005.04.002

10.1097/01.jcp.0000084032.22282.ff

10.1017/S1461145704004675

10.1016/S0924-977X(04)80133-0

10.1017/S0033291799001336

10.1176/ajp.151.5.640

10.1176/appi.ajp.162.1.151

10.1176/ajp.154.6.758

Friedman M J, 2000, Effective Treatments for PTSD: Practice Guidelines from the International Society for Stress Studies, 84

10.1080/13651500310004803

10.1017/S1461145799001546

10.1176/appi.ajp.160.11.1919

Gelpin E, 1996, J Clin Psychiatry, 57, 390

10.1176/ajp.152.10.1438

Goldberg D, 1987, J R Coll Gen Pract, 37, 15

10.1177/0269881103017002003

10.1016/j.euroneuro.2005.04.006

10.1016/S0005-7894(97)80048-2

10.1176/ajp.150.5.819

10.4088/JCP.v60n0702

10.4088/JCP.v63n0209

10.1017/S1092852900006908

10.1097/00004850-199506000-00001

10.1007/s10198-004-0272-z

10.1097/00004850-200301000-00001

10.1192/bjp.182.4.312

10.1136/bmj.324.7350.1350

10.1016/S0006-3223(01)01183-0

10.1001/archpsyc.55.12.1133

10.1159/000067188

10.1016/S0006-3223(99)00011-6

10.1097/00004714-200010000-00011

10.1001/archpsyc.57.1.76

10.1192/S0007125000297924

10.1017/S1461145703003730

10.4088/JCP.v64n0919

Hoyer J, 2003, Versicherungsmedizin, 55, 127

10.1176/appi.ajp.161.8.1485

10.1017/S109285290000225X

10.1017/S003329170300881X

Jorm A F, 2004, Med J Aust, 181, S29

10.4088/JCP.v63n0904

10.1002/14651858.CD003592

10.1001/archpsyc.59.12.1098

10.1016/0006-3223(90)90408-T

10.1046/j.1532-5415.2002.50003.x

10.1176/ajp.155.5.613

10.1001/archpsyc.1995.03950240066012

10.1001/archpsyc.1994.03950010008002

Kessler R C, 1999, Am J Psychiatry, 156, 1915, 10.1176/ajp.156.12.1915

10.1016/j.jpsychires.2004.06.005

10.1007/s002130050558

10.1192/S0007125000293513

10.1007/s002130050731

10.1002/da.20014

10.1016/S0165-0327(99)00097-X

10.1111/j.1600-0447.1997.tb00389.x

10.1016/S0924-9338(00)00216-9

10.1001/archpsyc.1989.01810110042006

10.1176/appi.ajp.162.1.146

10.4088/JCP.v59n1006

10.1192/bjp.157.6.860

10.1037/0022-006X.62.4.865

10.1016/j.euroneuro.2005.04.010

10.1001/archpsyc.62.2.190

10.4088/JCP.v63n0113

10.1002/(SICI)1520-6394(1999)10:3<89::AID-DA1>3.0.CO;2-5

10.1177/026988110401800321

10.4088/JCP.v63n1112

10.4088/JCP.v62n0503

10.1192/bjp.185.1.55

10.1097/00004714-199106000-00005

10.1001/archpsyc.1994.03950040046006

10.1001/archpsyc.57.8.794

10.1034/j.1600-0447.2000.102004256.x

10.1017/S0033291700052855

10.1192/bjp.152.4.522

10.1192/bjp.181.4.315

10.4088/JCP.v59n0808

10.1192/bjp.143.4.348

10.1001/archpsyc.56.9.821

Meibach R C, 1987, J Clin Psychiatry, 84, 355

Mendels J, 1986, J Clin Psychiatry, 47, 170

10.1002/da.10141

10.1192/bjp.174.3.213

10.1176/ajp.155.11.1570

10.1097/01.jcp.0000155821.74832.f9

10.1097/00004714-200102000-00011

10.1097/00004714-200304000-00012

10.1097/00004850-200103000-00002

10.1016/0924-977X(93)90266-O

10.1016/S0022-3956(02)00005-5

10.1097/00004850-199809000-00005

10.1097/00004714-198902000-00005

National Institute for Clinical Excellence, 2002, Guidance on the use of computerised cognitive behavioural therapy for anxiety and depression

National Institute for Clinical Excellence, 2004, Depression. Management of depression in primary and secondary care

National Institute for Clinical Excellence, 2004, The management of panic disorder and generalised anxiety disorder in primary and secondary care

National Institute for Clinical Excellence, 2004, Obsessive compulsive disorder: core interventions in the treatment of obsessive compulsive disorder and body dysmorphophobic disorder. Draft for consultation

National Institute for Clinical Excellence, 2005, Post-traumatic stress disorder. The management of PTSD in adults and children in primary and secondary care

10.1136/bmj.327.7422.1030

10.1176/appi.ajp.159.11.1889

10.1177/0269881103174019

10.1177/0269881105051987

10.1017/S1092852900009901

10.1227/01.NEU.0000064565.49299.9A

10.1192/bjp.167.3.374

10.1177/026988110101500314

10.1001/archpsyc.1991.01810320024004

10.1001/archpsyc.1993.01820220009001

10.1017/S0033291700036606

10.1016/S0005-7967(97)00028-4

10.1016/S0005-7967(98)00176-4

10.1176/appi.ajp.158.12.1989

10.1016/S0887-6185(00)00027-X

10.1097/01.jcp.0000117423.05703.e7

Parkerson G R Jr, 1997, Fam Med, 29, 177

10.1016/S0165-0327(00)00323-2

10.1097/00004714-199202000-00003

10.1097/00004714-199108000-00004

10.1016/S0006-3223(01)01279-3

Pollack M H, American College of Neuropsychopharmacology

Pollack M H, 1994, J Clin Psychiatry, 55, 200

10.1017/S109285290000691X

Power K G, 1990, Br J Gen Pract, 40, 289

10.1192/bjp.185.1.46

10.1034/j.1600-0447.2001.00263.x

Rasmussen S A, 1990, J Clin Psychiatry, 51, 10

10.1590/S0100-879X2001001000010

10.1192/S0007125000293458

10.1001/archpsyc.1990.01810220015002

10.1055/s-2007-1014455

10.1176/appi.ajp.157.6.968

10.1176/appi.ajp.160.4.749

10.1159/000012369

10.1192/bjp.171.5.427

Royal College of Psychiatrists, 2000, Neurosurgery for mental disorder. Report from the Neurosurgery Working Group of the Royal College of Psychiatrists

Royal College of Psychiatrists, 2005, Benzodiazepines: risks, benefits or dependence. A re-evaluation

10.1192/bjp.176.3.229

10.4088/JCP.v60n0713

10.1192/S0007125000293367

10.1192/S0007125000298395

Sasson Y, 1997, J Clin Psychiatry, 58, 7

Schatzberg A F, 1997, J Clin Psychiatry, 58, 5

10.1016/S0010-440X(00)80008-5

10.1016/S0006-3223(01)01270-7

10.1016/j.biopsych.2003.09.014

10.1176/ajp.155.5.630

10.1017/S1092852900006805

10.1016/0091-3057(88)90214-6

10.1136/bmj.318.7183.593

10.4088/JCP.v62n07a04

10.1002/da.20003

10.1016/0022-3999(94)90145-7

10.4088/JCP.v64n1107

10.1002/14651858.CD001206.pub2

10.4088/JCP.v63n0211

10.1017/S146114570300364X

Stein D J, 2004, Cochrane Library

10.1176/appi.ajp.159.10.1777

10.1001/archpsyc.57.11.1046

10.1176/appi.ajp.158.10.1725

10.1007/s00213-004-1957-9

10.1016/S0165-1781(00)00154-2

10.4088/JCP.v64n0305

10.4088/JCP.v64n1204

10.1176/ajp.153.5.636

10.1007/PL00014164

Tollefson G D, 1994, J Clin Psychiatry, 55, 69

10.1001/archpsyc.1994.03950070051010

10.1002/(SICI)1520-6394(1999)9:3<107::AID-DA2>3.0.CO;2-T

US Department of Health and Human Services, 1992, Acute pain management: operative or medical procedures and trauma

10.1016/S0006-3223(03)00412-8

10.1016/0165-0327(96)00030-4

10.1017/S1092852900006933

10.1097/00005053-199708000-00006

10.1093/fampra/cmh708

10.1002/(SICI)1099-0879(199809)5:3<126::AID-CPP153>3.0.CO;2-H

10.1007/BF02244898

10.4088/JCP.v63n0107

10.1001/archpsyc.61.11.1153

10.1192/S0007125000293471

10.1192/bjp.168.2.169

10.1176/appi.ajp.161.6.1066

Weissman M M, 1994, J Clin Psychiatry, 55, 5

Wheadon D, Annual Meeting of the American College of Neuro psychopharmacology

10.1192/S000712500029346X

10.1016/j.euroneuro.2005.04.012

10.31887/DCNS.2003.5.2/huwittchen

10.1111/j.0065-1591.2000.acp29-03.x

10.1097/00004850-200015060-00002

Wittchen H U, 2002, J Clin Psychiatry, 63, 24

World Health Organization, 1992, The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines

World Health Organization, 2004, WHO Guide to Mental and Neurological Health in Primary Care, 2

10.1192/bjp.176.6.544

10.1111/j.1600-0447.1983.tb09716.x

10.1097/00004583-199211000-00010

Thông tin
Thông tin xuất bản

Journal of Psychopharmacology

Tập 19 Số 6

567-596

Thông tin tác giả